Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:
“A valuable retrospective study on PD-L1 alteration after NAC in TNBC.
- 22% of patients with residual tumors showed alteration in PD-L1.
- Almost all of these alterations were negative to positive changes.
- Platinum use associated with increased PD-L1.
- PD-L1 positivity after NAC associated with better RFS.”
Proceed to the article.
Source: Yakup Ergün/X
